Remote Monitoring

Remote cardiac monitoring technologies enable patient health to be tracked outside the clinical setting. It can be used for longer term monitoring to help diagnosis arrhythmias or other cardiac conditions. Remote monitoring also can keep tabs on chronic conditions such as heart failure or hypertension and alert clinicians to worsening symptoms to avoid an acute care episode or hospitalization.

Unreliable? 76% of world’s blood pressure monitors have not been validated

Researchers examined data on more than 3,400 BP devices used all over the world. A significant majority of them were never clinically validated for accuracy. 

Thumbnail

American College of Cardiology announces new industry framework for developing cardiovascular solutions

The document, available in full for free, is the result of a collaboration with the Consumer Technology Association.

Remote monitoring with ICMs benefits patients with cardiac autonomic dysfunction

Researchers found that ICMs helped detect serious arrhythmic events in this patient population.

Doctor patient with masks

Data-driven ICM device management: EP’s ‘game-changer’ is building momentum

Sponsored by BIOTRONIK

The world of EP keeps getting busier and busier, and ICMs make it easier for clinicians to keep up. 

Thumbnail

Cardiologs puts its AI model up against the Apple Watch—and wins

The company reported that its deep neural network led to improved sensitivity and fewer unclassified findings. 

Thumbnail

Tracking false-positive alerts among cardiac patients

“The findings of this study highlight the need for strategies to reduce and manage the burden of false-positive ILR alerts,” the researchers said.

Monitoring high-risk patients for AFib fails to reduce stroke risk

"These findings might imply that not all AFib is worth screening for, and not all screen-detected AFib merits anticoagulation," researchers wrote. 

Thumbnail

Yes, Apple’s iPhone can interfere with implantable cardiac devices—here’s what you should know

This issue “has the potential to inhibit lifesaving therapies,” according to a new analysis in the Journal of the American Heart Association.